PUBLICATIONS · 19139430
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Mar 1
- First author
- Monk BJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Monk BJ
- type
- Author
- name
- Sill MW
- type
- Author
- name
- Burger RA
- type
- Author
- name
- Gray HJ
- type
- Author
- name
- Buekers TE
- type
- Author
- name
- Roman LD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Monk BJ
- type
- Author
- name
- Sill MW
- type
- Author
- name
- Burger RA
- type
- Author
- name
- Gray HJ
- type
- Author
- name
- Buekers TE
- type
- Author
- name
- Roman LD
- type
- Author
- bibliography ids
- nci-bib-b9c32c9757585076d365a293
- book metadata
- content sha256
- bd14ce9357c3ef55e559cd04822f62c933d0373e6353dfde1b782e12b4ef46a1
- document type
- citation
- dois
- 10.1200/JCO.2008.18.9043
- electronic publication date
- display
- 2009 Jan 12
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19139430
- immutable id
- pubmed:19139430@bd14ce9357c3ef55e559cd04822f62c933d0373e6353dfde1b782e12b4ef46a1
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 7
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1069-74
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19139430
- provenance
- batch id
- 27a383f06e5fc3d04fad
- provider
- NCBI PubMed ESummary
- record sha256
- 77b01da30f51c7ed3596d30755c35c349e4eb30bd040ff6bc702c3274edef320
- response sha256
- 51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
- retrieved at
- 2026-09-09T23:46:24.265787+00:00
- publication date
- display
- 2009 Mar 1
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Preserved source evidence · Not medical advice
Triangle